Survey comparing the treatment of central retinal... (2024 study) Skip to main content
Study Diving Hyperb Med 2024

Survey comparing the treatment of central retinal artery occlusion with hyperbaric oxygen in Australia and New Zealand with the recommended guidelines as outlined by the Undersea and Hyperbaric Medical Society

Emmerton W, Banham N, Gawthrope I, Diving Hyperb Med, 2024

Tier 2, Indexed

Automatically imported from PubMed based on relevance criteria.

Summary

What Researchers Did

Researchers surveyed hyperbaric medicine units in Australia and New Zealand about how they treat sudden vision loss from a blocked retinal artery, and compared this to official guidelines.

What They Found

This survey of 12 Australian and New Zealand hyperbaric units found that most cases were treated at a pressure lower than official guidelines recommend. Over the past five years, the units treated 146 cases of this condition, and 101 of those cases (69%) were initially treated at a pressure of 284 kPa (about 2.8 ATA). The researchers identified this pressure difference as the biggest gap between actual practice and the guidelines set by the Undersea and Hyperbaric Medical Society. The study found that few units strictly followed the guidelines.

What This Means for Canadian Patients

The abstract notes that hyperbaric oxygen treatment is considered to be of benefit for this type of sudden vision loss if started before permanent damage to the retina occurs. This survey did not test how well treatment worked; it only compared what pressure units used against the guideline recommendation. Patients in Canada should know that treatment protocols can vary between hyperbaric facilities, even when official guidelines exist.

Canadian Relevance

No direct Canadian connection identified. This survey covered hyperbaric units in Australia and New Zealand only.

Study Limitations

This was a survey of unit practices and guideline adherence, not a study of patient outcomes, so it cannot show whether the lower pressure commonly used affects how well patients recover.

This plain-language summary was generated with AI assistance from the study's abstract; it has not been individually reviewed by a clinician. Always consult the source study and a qualified healthcare professional. See our editorial policy.

Was this summary helpful?

Study Details

Study Type Study
Category Ocular / Retinal
Source Pubmed
PubMed ID 38870951
Year Published 2024
Journal Diving Hyperb Med
MeSH Terms Hyperbaric Oxygenation; Humans; Retinal Artery Occlusion; New Zealand; Australia; Practice Guidelines as Topic; Societies, Medical; Guideline Adherence; Surveys and Questionnaires; Health Care Surveys

Cite This Study

Share

Find a Canadian Clinic Treating Ocular / Retinal

Browse verified hyperbaric facilities across Canada.

View Canadian Facilities

Disclaimer: This study summary is provided for informational and educational purposes only. It does not constitute medical advice. The information presented reflects the findings of the original research authors and may not represent the views of Canada Hyperbarics. Always consult a qualified healthcare professional before making treatment decisions.

Last updated: March 19, 2026 | Reviewed by: Canada Hyperbarics Editorial Team | Editorial process | Research sources | Counts & methodology